SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Sexual violence part of 'everyday life' in parts of Sudan, charity says - 2Manual for Big name Work out schedules
- 3Hunger and makeshift shelters persist in north Caribbean nearly 2 months after Hurricane Melissa
- 4Terminal cancer diagnosis announced by JFK's granddaughter
- 5Fabricated statement about Malaysian national exam top scorers stokes racial sentiment
- Step by step instructions to Buy a Jeep Wrangler on a Senior's Spending plan
- Physicists and philosophers have long struggled to understand the nature of time: Here's why
- Step by step instructions to Boost the Eco-friendliness of Your Smash 1500.
- Carry Nature Inside with These Staggering Plant Decisions
- Von der Leyen: Paris meeting sends signal of unity for Ukraine
- Merz: 80% of Syrians in Germany should return in three years
- Scientists discover black hole flare with the light of 10 trillion suns
- Genome study reveals milestone in history of cat domestication
- Native artists in Texas and Mexico shared their vision of the universe for 4,000 years, ancient murals suggest
